PNPLA3 and metabolic dysfunction-associated steatotic liver disease: For instance, a missense mutation in human PNPLA3 (patatin-like phospholipase domain-containing 3 protein) is associated with increased hepatic fat deposition and hepatic inflammation, which makes the liver more susceptible for NAFLD [32].